These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27131967)

  • 21. Soluble guanylate cyclase redox state under hypoxia or hypoxia/reoxygenation in isolated monkey coronary arteries.
    Tawa M; Geddawy A; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Pharmacol Sci; 2014; 125(2):169-75. PubMed ID: 24859780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272.
    da Silva FH; Claudino MA; Báu FR; Rojas-Moscoso JA; Mónica FZ; De Nucci G; Antunes E
    Eur J Pharmacol; 2012 Aug; 688(1-3):49-55. PubMed ID: 22634166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice.
    Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E
    J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging does not affect soluble guanylate cyclase redox state in mouse aortas.
    Shimosato T; Tawa M; Iwasaki H; Imamura T; Okamura T
    Physiol Rep; 2016 May; 4(10):. PubMed ID: 27233303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
    Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
    Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis.
    Baldissera L; Squebola-Cola DM; Calixto MC; Lima-Barbosa AP; Rennó AL; Anhê GF; Condino-Neto A; De Nucci G; Antunes E
    Pulm Pharmacol Ther; 2016 Dec; 41():86-95. PubMed ID: 27816773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro.
    Kalsi JS; Rees RW; Hobbs AJ; Royle M; Kell PD; Ralph DJ; Moncada S; Cellek S
    J Urol; 2003 Feb; 169(2):761-6. PubMed ID: 12544359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
    Jones AW; Durante W; Korthuis RJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of relaxation and interaction with nitric oxide of the soluble guanylate cyclase stimulator BAY 41-2272 in mouse gastric fundus and colon.
    Cosyns SM; Lefebvre RA
    Eur J Pharmacol; 2012 Jul; 686(1-3):104-15. PubMed ID: 22575520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats.
    Jabs A; Oelze M; Mikhed Y; Stamm P; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Kopp M; Steven S; Schulz E; Stasch JP; Münzel T; Daiber A
    Vascul Pharmacol; 2015 Aug; 71():181-91. PubMed ID: 25869522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase.
    Thomazzi SM; Moreira J; De Nucci G; Antunes E
    Biochem Pharmacol; 2005 Mar; 69(6):875-82. PubMed ID: 15748699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.
    Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sGC activator BAY 60-2770 has potent erectile activity in the rat.
    Lasker GF; Pankey EA; Frink TJ; Zeitzer JR; Walter KA; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1670-9. PubMed ID: 23585129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells.
    Borges de Oliveira-Junior E; Thomazzi SM; Rehder J; Antunes E; Condino-Neto A
    Eur J Pharmacol; 2007 Jul; 567(1-2):43-9. PubMed ID: 17499238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of downstream target genes regulated by the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signal pathway in pulmonary hypertension.
    Zou L; Xu X; Zhai Z; Yang T; Jin J; Xiao F; Wang C
    J Int Med Res; 2016 Jun; 44(3):508-19. PubMed ID: 27048385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle.
    Báu FR; Mónica FZ; Priviero FB; Baldissera L; de Nucci G; Antunes E
    Eur J Pharmacol; 2010 Jul; 637(1-3):171-7. PubMed ID: 20399768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.